| MS | Maffuci syndrome; maladjustment score; mandibular series; Marfan syndrome; Marie-Strumpell [syndrome... |
|---|---|
| ACC | accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst... |
| DME | degenerative myoclonus epilepsy; dimethyl diester; dimethyl ether; diphasic meningoencephalitis; dir... |
| EMT | emergency medical tag; emergency medical team; emergency medical technician; emergency medical treat... |
| MTC | mass transfer coefficient; maximum tolerated concentration; maximum toxic concentration; medical tes... |
| new yellow enzyme | The d-amino-acid oxidase found in yeast, a flavoenzyme, which contains FAD as coenzyme instead of FMN as does NADPH dehydrogenase; so-called to distinguish it from Warburg's old yellow enzyme. Compare: amino acid oxidases. (05 Mar 2000) |
|---|---|
| New York Heart Association classification | A functional classification to assess cardiovascular disability. Class I: patients with cardiac disease without limitation of physical activity. Ordinary activity does not cause symptoms. Class II: patients with cardiac disease with slight limitation of activity; comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea or angina. Class III: patients with cardiac disease producing marked limitation of activity: comfortable at rest. Less than ordinary physical activity causes symptoms. Class IV: patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms may be present even at rest. (05 Mar 2000) |
| new zealand | A group of islands in the South Pacific Ocean. New Zealand flax. <botany> A myrtaceous shrub (Leptospermum scoparium) of new Zealand and Australia, the leaves of which are used as a substitute for tea. Source: Websters Dictionary (01 Mar 1998) |
| New Zealand mice | Inbred strains of mice, either black (NZB) or white (NZW), unique among strains used in experimental immunology because of their proclivity to spontaneous immunologic abnormalities and disorders including systemic lupus erythematosus similar to that found in humans. (05 Mar 2000) |
| investigational new drug | Status given an experimental drug after the FDA approves an application for testing it in people. (09 Oct 1997) |
| investigational new drug application | An application that must be submitted to a regulatory agency (the FDA in the united states) before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. (12 Dec 1998) |
| academic medical centres | Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc. (12 Dec 1998) |
| advance medical directives | Advance directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes. There ared two basic types of advance directives: (1) a living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers; (2) a health care proxy (also called a power of attorney for healthcare decision making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions. Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (This entry is based upon material from the National MS Society). (12 Mar 2000) |
| american medical association | Professional society representing the field of medicine. (12 Dec 1998) |
| genetics, medical | A field of human genetics which entails the reliable prediction of certain human disorders as a function of the lineage and/or genetic makeup of any two parents or potential parents. (12 Dec 1998) |
| reference books, medical | Books in the field of medicine intended primarily for consultation. (12 Dec 1998) |
| regional medical programs | Coordination of activities and programs among health care institutions within defined geographic areas for the purpose of improving delivery and quality of medical care to the patients. These programs are mandated under u.s. Public law 89-239. (12 Dec 1998) |
| medical | Pertaining to medicine or to the treatment of diseases, pertaining to medicine as opposed to surgery. (18 Nov 1997) |
| medical anatomy | Anatomy in its bearing upon the diagnosis and treatment of diseases. (05 Mar 2000) |
| medical assistance | Financing of medical care provided to public assistance recipients. (12 Dec 1998) |